Hostname: page-component-7b7567c8c-wxvwp Total loading time: 0 Render date: 2026-11-17T15:51:25.268Z Has data issue: false hasContentIssue false

Ascorbic Acid and Chronic Schizophrenia

Published online by Cambridge University Press:  29 January 2018

Brice Pitt
Affiliation:
Churchill Clinic, Princess Alexandra Hospital, Harlow, Essex. (Late Consultant Psychiatrist, Claybury Hospital, Woodford Bridge, Essex)
Norman Pollitt
Affiliation:
Roche Products Ltd., Welwyn Garden City, Herts.; Clinical Assistant, Department of Medicine, West London Hospital, London, W.6
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

Milner (1963), using urinary saturation tests to determine ascorbic acid levels in a group of male chronic schizophrenics, reported that far higher doses of ascorbic acid were required to achieve saturation in that group than in normal subjects. Briggs (1962) observed hypovitaminosis C in schizophrenics, and postulated a disturbance of ascorbic acid metabolism which could be relevant to the biochemical basis of schizophrenia.

Information

Type
Research Article
Copyright
Copyright © The Royal College of Psychiatrists, 1971 

This journal is not currently accepting new eletters.

eLetters

No eLetters have been published for this article.